Kyle Goodknight introduces Kimberly Wallbank, who shares her expertise on quality systems and navigating FDA consent decree challenges. The discussion covers effective corporate communication, process improvement, and the use of relatable analogies in consulting. Kimberly addresses internal resistance within the pharmaceutical industry and the intricacies of performance reviews and corporate politics. They delve into medical device recalls, FDA reporting, and Kimberly's transition from a corporate role to consulting. She offers entrepreneurial advice, discusses consulting market challenges, and provides an overview of her consulting services.

Ver todos los episodios